Chronic administration of a glycine partial agonist alters the expression of N-methyl-D-aspartate receptor subunit mRNAs

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1503-1508

  Bovetto, S ^a   Boyer, P A ^a   Skolnick, P ^a,b   Fossom, L H ^a,c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; GLYCINE RECEPTOR AGONIST; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SPINAL CORD ISCHEMIA;

AMINO ACIDS; AMINO ACIDS, CYCLIC; ANIMALS; CEREBELLUM; CEREBRAL CORTEX; HIPPOCAMPUS; MALE; MICE; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER;

EID: 0031470569     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 3H]5,7-Dichlorokynurenic acid, a novel radioligand labels NMDA receptor associated glycine binding sites. Eur. J. Pharmacol. 206: 149-154, 1991.
2. BLANDINI, F., PORTER, R. H. AND GREENAMYRE, J. T.: Glutamate and Parkinson's disease. Mol. Neurobiol. 12: 73-94, 1996.
3. BOJE, K. M., WONG, G. AND SKOLNICK, P.: Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar cell cultures. Brain Res. 603: 207-214, 1993.
4. CARTER, A. J.: Glycine antagonists: Regulation of the NMDA receptor-channel complex by the strychnine-insensitive glycine site. Drugs Future 17: 595-613, 1992.
5. CHERKOFSKY, S. C.: 1-Aminocyclopropanecarboxylic acid: mouse to man interspecies pharmacokinetic comparisons and allometric relationships. J. Pharm. Sci. 84: 1231-1235, 1995.
6. CHOI, D.: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634, 1988.
7. CHOI, D. W.: Excitotoxic cell death. J. Neurobiol. 23: 1261-1276, 1992.
8. 3H]-noradrenaline release in rat hippocampal synaptosomes. Br. J. Pharmacol. 118: 901-904, 1996.
9. FOSSOM, L. H., BASILE, A. S. AND SKOLNICK, P.: Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition. Mol. Pharmacol 48: 981-987, 1995a.
10. FOSSOM, L. H., VON LUBITZ, D. K. J. E., LIN, R. C.-S. AND SKOLNICK, P.: Neuroprotective actions of 1-aminocyclopropanecarboxylic acid (ACPC): A partial agonist at strychnine-insensitive glycine sites. Neurol. Res. 17: 265-269, 1995b.
11. GLOBUS, M. Y.-T., BUSTO, R., MARTINEZ, E., VALDES, I., DIETRICH, W. D. AND GINSBERG, M. D.: Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J. Neurochem. 57: 470-478, 1991.
12. GREENE, J. G. AND GREENAMYRE, J. T.: Bioenergetics and glutamate excitotoxicity. Prog. Neurobiol. 48: 613-634, 1996.
13. HUETTNER, J. E.: Indole-2-carboxylic acid: a competitive antagonist of potentiation by glycine at the NMDA receptor. Science 243: 1611-1613, 1989.
14. KLECKNER, N. W. AND DINGLEDINE, R.: Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241: 835-837, 1988.
15. KUTSUWADA, T., KASHIWABUCHI, N., MORI, H., SAKIMURA, K., KUSHIYA, E., ARAKI, K., MEGURO, H., MASAKI, H., KUMANISHI, T., ARAKAWA, M. AND MISHINA, M.: Molecular diversity of the NMDA receptor channel. Nature 358: 36-41, 1992.
16. LAURIE, D. J. AND SEEBURG, P. H.: Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. 268: 335-345, 1994.
17. LONG, J. B. AND SKOLNICK, P.: 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury. Eur. J. Pharmacol. 261: 295-301, 1994.
18. LYNCH, D. R., ANEGAWA, N. J., VERDOORN, T. AND PRITCHETT, D. B.: N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents. Mol. Pharmacol 45: 540-545, 1994.
19. MACCECCHINI, M. L.: Partial agonism and neuroprotection. In Ischemic Stroke: Recent Advances in Understanding & Therapy, ed. by Grotta, J., Miller, L. P. and Buchan, A. M., eds., chap. 2.7, pp 140-168, International Business Communications, Southboro, 1995.
20. MARVIZON, J. C., LEWIN, A. H. AND SKOLNICK, P.: 1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex. J. Neurochem. 52: 992-994, 1989.
21. MONYER, H., SPRENGEL, R., SCHOEPFER, R., HERB, A., HIGUCHI, M., LOMELI, H., BURNASHEV, N., SAKMANN, B. AND SEEBURG, P.: Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256: 1217-1221, 1992.
22. MORI, H. AND MISHINA, M.: Structure and function of the NMDA receptor channel. Neuropharmacology 34: 1219-1237, 1995.
23. MORIYOSHI, K., MASU, M., ISHII, T., SHIGEMOTO, R., MIZUNO, N. AND NAKANISHI, S.: Molecular cloning and characterization of the rat NMDA receptor. Nature 354: 31-36, 1991.
24. MUIR, K. W., GROSSET, D. G., GAMZU, E. AND LEES, K. R.: Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers. Br. J. Clin. Pharmacol. 38: 33-38, 1994.
25. NOWAK, G., TRULLAS, R., LAYER, R. T., SKOLNICK, P. ANd PAUL, I. A.: Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J. Pharmacol. Exp. Ther. 265: 1380-1386, 1993.
26. OLNEY, J.: Excitatory amino acids and neuropsychiatrie disorders. Biol. Psychiatry 26: 505-525, 1989.
27. OSSOWSKA, K.: The role of excitatory amino acids in experimental models of Parkinson's disease. J. Neural Transm. Park. Dis. Dement. Sect. 8: 39-71, 1994.
28. PALFREYMAN, M. G., REYNOLDS, I. J. AND SKOLNICK, P., EDS.: Pharmacology and Toxicology: Basic and Clinical Aspects: Direct and Allosteric Control of Glutamate Receptors, CRC Press, Boca Raton, FL, 1994. (N)
29. PIZZI, M., FALLACARA, C., ARRIGHI, V., MEMO, M. AND SPANO, P.: Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. J. Neurochem. 61: 683-689, 1993.
30. ROBINSON, M. AND COYLE, J.: Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application. FASEB J. 1: 446-455, 1987.
31. SHEARDOWN, M. J., SUZDAK, P. J. AND NORDHOLM, L.: AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur. J. Pharmacol. 236: 347-353, 1993.
32. SHENG, M., CUMMINGS, J., ROLDAN, L. A., JAN, Y. N. AND JAN, L. Y.: Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368: 144-147, 1994.
33. SIMMONS, D. M., ARRIZA, J. L. AND SWANSON, L. W.: A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabelled single-stranded RNA probes. J. Histotechnol. 12: 169-181, 1989.
34. SKOLNICK, P., MARVIZON, J., JACKSON, B., MONN, J., RICE, K. AND LEWIN, A.: Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci. 45: 1647-1655, 1989.
35. SVEINBJORNSDOTTIR, S., SANDER, J. W. A. S., UPTON, D., THOMPSON, P. J., PATSALOS, P. N., HIRT, D., EMRE, M., LOWE, D. AND DUNCAN, J. S.: The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res. 16: 165-174, 1993.
36. VON LUBITZ, D. K. J. E., LIN, R. C.-S., MCKENZIE, R. J., DEVLIN, T. M., MCCABE, R. T. AND SKOLNICK, P.: A novel treatment of global cerebral ischaemia with a glycine partial agonist. Eur. J. Pharmacol. 219: 153-158, 1992.
37. WAFFORD, K. A., BAIN, C. J., LE BOURDELLES, B., WHITING, P. J. AND KEMP, J. A.: Preferential co-assembly of recombinant NMDA receptors composed of three different subunits. NeuroReport 4: 1347-1349, 1993.
38. WATSON, G. AND LANTHORN, T. H.: Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site. Neuropharmacology 29: 727-730, 1990.
39. WITKIN, J. M., BRAVE, S., FRENCH, D. AND GETER-DOUGLASS, B.: Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor. J. Pharmacol. Exp. Ther. 275: 1267-1273, 1995.
40. ZAPATA, A., CAPDEVILA, J. L., VIU, E. AND TRULLAS, R.: 1-Aminocyclopropanecarboxylic acid reduces NMDA-induced hippocampal neurodegeneration in vivo. NeuroReport 7: 397-400, 1996.